Semi-Annual Consolidated Statement Of Income

D.Western Therapeutics Institute, Inc. - Filing #7609939

Concept 2022-01-01 to
2022-03-31
2021-01-01 to
2021-03-31
Semi-annual consolidated statement of income
Statement of income
Net sales
109,717,000 JPY
89,688,000 JPY
Cost of sales
7,001,000 JPY
3,916,000 JPY
Ordinary profit (loss)
-26,107,000 JPY
-40,944,000 JPY
Gross profit (loss)
102,715,000 JPY
85,771,000 JPY
Selling, general and administrative expenses
Selling, general and administrative expenses
140,706,000 JPY
136,576,000 JPY
Operating profit (loss)
-37,991,000 JPY
-50,805,000 JPY
Profit (loss) before income taxes
-26,107,000 JPY
-40,944,000 JPY
Non-operating income
Interest income
13,000 JPY
9,000 JPY
Non-operating income
12,794,000 JPY
11,190,000 JPY
Income taxes - current
398,000 JPY
398,000 JPY
Non-operating expenses
Interest expenses
886,000 JPY
1,216,000 JPY
Non-operating expenses
910,000 JPY
1,330,000 JPY
Income taxes
398,000 JPY
398,000 JPY
Profit (loss)
-26,506,000 JPY
-41,343,000 JPY
Profit (loss) attributable to non-controlling interests
-4,644,000 JPY
JPY
Profit (loss) attributable to owners of parent
-21,861,000 JPY
-41,343,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
-569,000 JPY
JPY
Other comprehensive income
-569,000 JPY
JPY
Comprehensive income
-27,075,000 JPY
-41,343,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
-22,431,000 JPY
-41,343,000 JPY
Comprehensive income attributable to non-controlling interests
-4,644,000 JPY
JPY
Profit attributable to

Talk to a Data Expert

Have a question? We'll get back to you promptly.